Related Experiment Video
Updated: Mar 15, 2026
06:39
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
3.9K
Sleep disorders in Pregnancy: Glycaemic implications
1Departments of Endocrinology, Command Hospital, Chandimandir, India.
JPMA. the Journal of the Pakistan Medical Association
|September 2, 2016
Summary
Sleep disorders during pregnancy negatively impact maternal and fetal health, leading to serious cardio-metabolic issues like insulin resistance and hyperglycemia. This review explores their pathophysiology and glycaemic effects.
Area of Science:
- Physiology
- Sleep Medicine
- Obstetrics
Background:
- Sleep is a vital biorhythm for bodily restoration, regulated by the circadian center.
- Sleep duration has decreased due to urbanization, increasing sleep disorders like insomnia and sleep-disordered breathing.
- Sleep disorders are linked to adverse cardio-metabolic outcomes, including insulin resistance and hyperglycemia.
Purpose of the Study:
- To review the pathophysiology of sleep disorders during pregnancy.
- To examine the glycaemic implications of sleep disorders in pregnant individuals.
- To highlight adverse foeto-maternal outcomes and long-term cardiovascular risks.
Main Methods:
- Literature review of sleep disorders during pregnancy.
- Analysis of physiological changes affecting sleep in pregnancy.
- Examination of glycaemic control and metabolic consequences.
Main Results:
- Pregnancy significantly alters physiological homeostasis, increasing susceptibility to sleep disorders.
- Sleep disorders in pregnancy are associated with adverse foeto-maternal outcomes.
- These disorders contribute to long-term cardiovascular implications and metabolic disturbances.
Conclusions:
- Sleep disorders during pregnancy present significant risks to both mother and fetus.
- Understanding the pathophysiology and glycaemic implications is crucial for managing these risks.
- Interventions addressing sleep disturbances may improve maternal and fetal health outcomes.
More Related Videos
Related Concept Videos
01:20Pathophysiology of Diabetes
4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
01:22Diabetes Mellitus: Type 2 and Gestational
5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
01:15Hypoglycemia and Glucagon
1.2K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
753
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
753
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
778
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
778
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K